Showing results (191-200 of 1,898) with videos related to
Sort By:
Pageof 190
Current Neuropharmacology|April 15, 2025
Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's DiseaseMatheus Chimelo Bianchini, Francini Franscescon, Adinei Abadio Soares, et al.Current Neuropharmacology|April 7, 2025
The Potential Role of Glutamate Receptors and their Antagonists or Modulators in Migraine TherapyChih-Hung Tsai, Ming-Chi Lai, Chin-Wei HuangCurrent Neuropharmacology|May 12, 2025
Research Trends and Knowledge Atlas of Radiotherapy-Related Cognitive Impairment: A Bibliometric AnalysisYaqian Tan, Qi Song, Siyuan GaoCurrent Neuropharmacology|March 28, 2025
Synthetic Derivates of Progesterone Ameliorate Scopolamine-Induced Cognitive Deficits in Animal Models: Antioxidant, Enzyme Inhibitory, Molecular Docking and Behavioral CorrelatesAsif Nawaz, Abdul Sadiq, Nasreena Bashir, et al.Current Neuropharmacology|August 13, 2025
The Cathepsin Family in Disease: From Molecular Mechanisms to Therapeutic ApplicationsLorca Alzoubi, Yassmen Hamzat, Alaa Alqudah, et al.Current Neuropharmacology|August 8, 2025
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia GravisChi Ma, Jingyi Shen, Ying Zhu, et al.Current Neuropharmacology|August 13, 2025
Inhibition of the P2Y2 Receptor Promotes Facial Nerve Function by Enhancing Neuron AutophagyXianmin Song, Yingna Gao, Minhui Zhu, et al.Current Neuropharmacology|August 11, 2025
Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on ImmunometabolitesGiulio Papiri, Cristina Paci, Giordano D'andreamatteo, et al.Current Neuropharmacology|October 22, 2025
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer's DiseaseQi Qu, Yanfei Tong, Shengwu Liao, et al.Current Neuropharmacology|October 24, 2025
Impaired Glucose Metabolism in Young Patients with First-episode Schizophrenia Aged from 16 to 35 YearsJing Yao, Nan Chen, Meihong Xiu, et al.Pageof 190